Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity

Sivick, Kelsey E., Desbien, Anthony L., Glickman, Laura Hix, Reiner, Gabrielle L., Corrales, Leticia, Surh, Natalie H., Hudson, Thomas E., Vu, Uyen T. +17 more·2018·Cell Reports

DOI 10.1016/j.celrep.2018.11.047

Cited by (457)

Items 201–300 of 457

STING Contributes to Cancer-Induced Bone Pain by Promoting M1 Polarization of Microglia in the Medial Prefrontal Cortex
Xiaoxuan Zhang, Xin Li, Wei Wang, Yuxin Zhang, Zhihao Gong, Yuan Peng, Jingxiang Wu, Xingji You · 2022 · Cancers
Mn-phenolic networks as synergistic carrier for STING agonists in tumor immunotherapy
Yingcai Meng, Jiaxin Huang, Jinsong Ding, Haiyan Zhou, Yong Li, Wenhu Zhou · 2024 · Materials Today Bio
Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance
Yihang Gao, Chongchong Feng, Jingru Ma, Qingzhu Yan · 2024 · Biochemical Pharmacology
Small molecular drugs reshape tumor microenvironment to synergize with immunotherapy
Chuanhui Han, Anli Zhang, Zhida Liu, Casey Moore, Yang‐Xin Fu · 2020 · Oncogene
Flotillin-1 enhances radioresistance through reducing radiation-induced DNA damage and promoting immune escape via STING signaling pathway in non-small cell lung cancer
Yingying Wang, Lu Meng, Shuyan Meng, Litang Huang, Shilan Luo, Xiaoting Wu, Xiaomei Gong · 2023 · Cancer Biology & Therapy
Delivery of Stimulator of Interferon Genes (STING) Agonist Using Polypeptide‐Modified Dendrimer Nanoparticles in the Treatment of Melanoma
Pere Dosta, Alexander M. Cryer, Michaela Prado, Michelle Z. Dion, Shiran Ferber, Santhosh Kalash Rajendrakumar, Natalie Artzi · 2021 · Advanced NanoBiomed Research
Design of a systemic small molecule clinical STING agonist using physics-based simulations and artificial intelligence
Bryce K. Allen, Meghana M. Kulkarni, Brian T. Chamberlain, Timothy Dwight, Cheryl M. Koh, Ramya Samant, Finith E. Jernigan, Jamie Rice, Dazhi Tan, Stella Li et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Bridging innate and adaptive tumor immunity: cGAS–STING pathway activation to potentiate immune checkpoint blockade
Zhuo Ya Li, Wei Zheng, Yisi Liu, Rong Cao, Jing Wei, Haiqing Jia · 2025 · Journal of Experimental & Clinical Cancer Research
No Longer A One-Trick Pony: STING Signaling Activity Beyond Interferon
Jianjun Wu, Nan Yan · 2021 · Journal of Molecular Biology
Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME
Vijay Kumar, Caitlin Bauer, John H. Stewart · 2023 · Journal of Biomedical Science
Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity
Zachary T. Morrow, Zachary M. Powers, John‐Demian Sauer · 2019 · Current Clinical Microbiology Reports
Secrets of DNA-PKcs beyond DNA repair
Sydney Camfield, Sayan Chakraborty, Shailendra Kumar Dhar Dwivedi, Pijush Kanti Pramanik, Priyabrata Mukherjee, Resham Bhattacharya · 2024 · npj Precision Oncology
Next Steps for Immunotherapy in Glioblastoma
Toni Cao, Derek A. Wainwright, Catalina Lee-Chang, Jason M. Miska, Adam M. Sonabend, Amy B. Heimberger, Rimas Vincas Lukas · 2022 · Cancers
Biomaterial-enabled therapeutic modulation of cGAS-STING signaling for enhancing antitumor immunity
Yingqi Liu, Fei Yang, Xuan Wang, Bingbing Yang, Menghuan Li, Zhong Yuan Luo · 2023 · Molecular Therapy
STING Activation and its Application in Immuno-Oncology
Yiqian Lian, Kevin J. Duffy, Jingsong Yang · 2019 · Current Topics in Medicinal Chemistry
Amphiphilic Polyelectrolyte Graft Copolymers Enhance the Activity of Cyclic Dinucleotide STING Agonists
Dinh Chuong Nguyen, Daniel Shae, Hayden M. Pagendarm, Kyle W. Becker, Mohamed Wehbe, Kameron V. Kilchrist, Lucinda E. Pastora, Christian R. Palmer, Pedro Seber, Plamen P. Christov et al. · 2020 · Advanced Healthcare Materials
Metallic nanomedicine in cancer immunotherapy
Shixuan Li, Xiaohu Wang, Huiyun Han, Shuting Xiang, Mingxi Li, Guangyu Long, Yanming Xia, Qiang Zhang, Suxin Li · 2025 · Acta Pharmaceutica Sinica B
Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential
Milan Dejmek, Michal Šála, Andrea Brázdová, Lenka Vaneková, Miroslav Smola, Martin Klíma, Petra Břehová, Miloš Buděšı́nský, Martin Dračínský, Eliška Procházková et al. · 2022 · Structure
A novel 18F-labeled agonist for PET imaging of stimulator of interferon gene expression in tumor-bearing mice
Jianyang Fang, Lixia Feng, Lingxin Meng, Xiaobo Wang, Huanhuan Liu, Lumei Huang, Deliang Zhang, Jingchao Li, Rongqiang Zhuang, Zhide Guo et al. · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
GAS-STING: a classical DNA recognition pathways to tumor therapy
Xinrui Wang, Meijia Lin, Liping Zhu, Zhoujie Ye · 2023 · Frontiers in Immunology
STING activator 2′3′‐ cGAMP enhanced HSV ‐1‐based oncolytic viral therapy
Patricia Angela Sibal, Shigeru Matsumura, Toru Ichinose, Itzel Bustos‐Villalobos, Daishi Morimoto, Ibrahim Ragab Eissa, Mohamed Abdelmoneim, Mona Alhussein Aboalela, Nobuaki Mukoyama, Maki Tanaka et al. · 2024 · Molecular Oncology
Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models
Andreas Jekle, Santosh Kumar Thatikonda, Ruchika Jaisinghani, Suping Ren, April Kinkade, Sarah Stevens, Antitsa D. Stoycheva, Vivek K. Rajwanshi, Caroline T. Williams, Jérôme Deval et al. · 2023 · International Journal of Molecular Sciences
Intrinsic STING of CD8 + T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects
Qiuli Xu, Xin Hua, Bingbing Li, Bei Jiang, Jiajia Jin, Ranpu Wu, Yanli Gu, Hao Xu, Qinpei Cheng, Suhua Zhu et al. · 2025 · Cell Communication and Signaling
Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
Eric de Sousa, Joana R. Lérias, Antonio Lopez-beltran B, Georgia Paraschoudi, Carolina Condeço, Jéssica Kamiki, Patrícia António, Nuno Figueiredo, Carlos Torres Carvalho, Mireia Castillo-Martín et al. · 2021 · Frontiers in Immunology
Computational design of constitutively active cGAS
Quinton M. Dowling, Hannah E. Volkman, Elizabeth E. Gray, Sergey Ovchinnikov, Stephanie Cambier, Asim K. Bera, Banumathi Sankaran, Max R. Johnson, Matthew J. Bick, Alex Kang et al. · 2023 · Nature Structural & Molecular Biology
Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist
Ruochen Zang, Liang Xue, Meifang Zhang, Xiaoyue Peng, Xionghao Li, Kaixin Du, Chuanqin Shi, Yuqian Liu, Yuxi Lin, Wenwei Han et al. · 2023 · European Journal of Medicinal Chemistry
Fine-tuning Bacterial Cyclic di-AMP Production for Durable Antitumor Effects Through the Activation of the STING Pathway
Yu Jiang, Xiyuan Li, Fenghui Qian, Bingbing Sun, Xiyuan Wang, Yan Zhang, Deqiang Zhang, Meiyu Geng, Zuoquan Xie, Sheng Yang · 2023 · Research
STAT2 hinders STING intracellular trafficking and reshapes its activation in response to DNA damage
Chenyao Wang, Nan Jing, Elise G. Holvey-Bates, Xing Chen, Samantha M. Wightman, Muhammad-Bilal Latif, Junjie Zhao, Xiaoxia Li, Ganes C. Sen, George Robert Stark et al. · 2023 · Proceedings of the National Academy of Sciences
Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models
Efthymia Papaevangelou, Ana M. Esteves, Prokar Dasgupta A, Christine Galustian · 2023 · Frontiers in Immunology
Stimulating STING for cancer therapy: Taking the extracellular route
Lingyin Li · 2024 · Cell chemical biology
Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8+ T cell-dependent anti-tumor immunity
Joanna L. Turley, Ross W. Ward, Jorge Huete‐Carrasco, Natalia Muñoz‐Wolf, Kate Roche, Lei Jin, Andrew Bowie, Mats Andersson, Ed C. Lavelle · 2024 · Cell Reports Medicine
Inhibition of CPT1A activates the cGAS/STING pathway to enhance neutrophil-mediated tumor abrogation in triple-negative breast cancer
Chenglong Li, Tingfang Gao, Qiuling Zhao, Zhi Li, Zhidong Wang, Shuaishuai Ding, Mengsi Zhang, Yan Qin, Xinwen Xue, Xiao Zhang et al. · 2025 · Cancer Letters
Regulation of the Cell-Intrinsic DNA Damage Response by the Innate Immune Machinery
Thomas J. Hayman, Peter M. Glazer · 2021 · International Journal of Molecular Sciences
Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis
Wei Xie, Leiying Zhang, Junjing Shen, Fengdi Lai, Wenling Han, Xiaoyan Liu · 2024 · BMC Cancer
Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context
Justyna Czapla, Alina Drzyzga, Sybilla Matuszczak, Tomasz Cichoń, Marek Rusin, Magdalena Jarosz–Biej, Ewelina Pilny, Ryszard Smolarczyk · 2023 · Frontiers in Oncology
The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors
Alina Drzyzga, Tomasz Cichoń, Justyna Czapla, Magdalena Jarosz–Biej, Ewelina Pilny, Sybilla Matuszczak, Piotr Wojcieszek, Zbigniew Urbaś, Ryszard Smolarczyk · 2021 · Cancers
Nano-delivery of STING agonists: Unraveling the potential of immunotherapy
Meng Zhang, Yating Ji, Mingxia Liu, Yixin Dai, Hongxia Zhang, Shiyu Tong, Yuqing Cai, Mengjiao Liu, Na Qu · 2025 · Acta Biomaterialia
AND logic nanoparticle for precision immunotherapy of metastatic cancers
Shuyue Ye, Shuang Chen, Vijay S. Basava, Katy Torres, Yangyang Zhao, Gang Huang, Mingyi Chen, Jinming Gao · 2026 · Nature Nanotechnology
High levels of tumor cell-intrinsic STING signaling are associated with increased infiltration of CD8+ T cells in dMMR/MSI-H gastric cancer
Ryo Kanoda, Shotaro Nakajima, Satoshi Fukai, Motonobu Saito, Katsuharu Saito, Hiroya Suzuki, Tomohiro Kikuchi, Azuma Nirei, Hirokazu Okayama, Kosaku Mimura et al. · 2024 · Scientific Reports
EXOTLR1/2-STING: A Dual-Mechanism Stimulator of Interferon Genes Activator for Cancer Immunotherapy
Tianyang Wang, Hong‐Guo Hu, Lang Zhao, Shao‐Hua Zhuo, Jingyun Su, Geng-Hui Feng, Yanmei Li · 2025 · ACS Nano
Nanomedicinal Delivery of Stimulator Of Interferon Genes Agonists: Recent Advances in Virus Vaccination
Saborni Chattopadhyay, Che‐Ming Jack Hu · 2020 · Nanomedicine
STING Signaling and Skin Cancers
Sayaka Sato, Yu Sawada, Motonobu Nakamura · 2021 · Cancers
Newly synthesized AIFM1 determines the hypersensitivity of T lymphocytes to STING activation-induced cell apoptosis
Wangsheng Ji, Lianfei Zhang, Chengxin Ma, Xiaoyu Xu, Shuai Li, Huan Xia, Weihong Zhou, Xinqi Liu · 2023 · Cell Reports
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice
Satoru Akazawa, Leanne Mackin, Gaurang Jhala, Stacey Fynch, Tara Catterall, Claudia Selck, Kate L. Graham, Balasubramanian Krishnamurthy, Evan G. Pappas, Chun-Ting J. Kwong et al. · 2021 · Diabetologia
Cell-type specific activation of the cGAS-STING pathway in tumor immunotherapy: mechanisms and therapeutic implications
Lusheng Wang, Sudi Zhu, Zhixian Ding, Jie Hong, Lijie Zheng, Jiting Sun, Yu Tang, Xiaohui Chen, Xiang Yong, Mengxue Hu et al. · 2026 · Journal of Translational Medicine
STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
Samanthi A. Perera, Johnny E. Kopinja, Yanhong Ma, Eric S. Muise, Jason Laskey, Kalyan Chakravarthy, Yiping Chen, Long Cui, Jeremy P. Presland, Manjiri Sathe et al. · 2021 · Molecular Cancer Therapeutics
Heterogeneity of the tumor immune microenvironment and clinical interventions
Zheng Jin, Qin Zhou, Jianan Cheng, Qingzhu Jia, Bo Zhu · 2023 · Frontiers of Medicine
Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapy
Justyna Czapla, Alina Drzyzga, Joanna Ciepła, Sybilla Matuszczak, Magdalena Jarosz–Biej, Ewelina Pilny, Tomasz Cichoń, Ryszard Smolarczyk · 2024 · Cancer Immunology Immunotherapy
Make it STING: nanotechnological approaches for activating cGAS/STING as an immunomodulatory node in osteosarcoma
Jordan C. O’Donoghue, Fiona E. Freeman · 2024 · Frontiers in Immunology
What role of the cGAS-STING pathway plays in chronic pain?
Jingxiang Wu, Xin Li, Xiaoxuan Zhang, Wei Wang, Xingji You · 2022 · Frontiers in Molecular Neuroscience
Distinct oligomeric assemblies of STING induced by non-nucleotide agonists
Anant Gharpure, Ariana Sulpizio, Johannes R. Loeffler, Monica L. Fernández‐Quintero, Andy S. Tran, Luke L. Lairson, Andrew B. Ward · 2025 · Nature Communications
Ferroptosis and the cGAS–STING pathway into precision nano-immuno-theranostics: A mechanistic paradigm for reversing drug resistance in hepatocellular carcinoma
Alaa Elmetwalli · 2025 · Drug Resistance Updates
Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy
Milan Dejmek, Andrea Brázdová, Tomáš Otava, Marketa Pimkova Polidarova, Martin Klíma, Miroslav Smola, Zdeněk Vavřina, Miloš Buděšı́nský, Martin Dračínský, Radek Liboska et al. · 2023 · European Journal of Medicinal Chemistry
Prognostic significance of STING expression in solid tumor: a systematic review and meta-analysis
Young-Hoon Kim, Nam-Yun Cho, Lingyan Jin, Hye Yeong Jin, Gyeong Hoon Kang · 2023 · Frontiers in Oncology
Potentiating the Systemic Immunity by Bacteria‐Delivered Sting Activation in a Tumor Microenvironment
Wenfei Chen, Yining Zhu, Jiahao Chen, Xiandan Jing, Yimin Xiong, Ling Zou, Jiahui Li, Qinhui Liu, Yanping Li, Yuan Huang et al. · 2023 · Advanced Functional Materials
STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy
Bandarigoda Nipunika Somatilaka, Laasya Madana, Ali Sadek, Zhiguo Chen, Sanjay Chandrasekaran, Renée M. McKay, Lu Q. Le · 2024 · Journal of Clinical Investigation
Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses
Thomas Pulliam, Saumya Jani, Peter H. Goff, Rashmi Bhakuni, Shira Tabachnick‐Cherny, Kimberly S. Smythe, Brandon W. Seaton, Lisa May Ling Tachiki, Rima M. Kulikauskas, Candice D. Church et al. · 2024 · Journal for ImmunoTherapy of Cancer
Coimmunomodulation of tumor and tumor-draining lymph nodes during in situ vaccination promotes antitumor immunity
Moonkyoung Jeong, Heegon Kim, Junyong Yoon, Dong‐Hyun Kim, Ji‐Ho Park · 2022 · JCI Insight
Bioinspired nucleic acid structures for immune modulation
Cameron Louttit, Kyong Soo Park, James Jaehyun Moon · 2019 · Biomaterials
Therapeutic targeting of cGAS–STING pathway in lung cancer
Jinli Wang, Lumin Xing · 2024 · Cell Biology International
Limitations of CAR-T-Cell Therapy in Hematologic Malignancies: Focusing on Antigen Escape and T-Cell Dysfunction
Yanyu Lin, Shuqi Luo, Jianhui Wei, Shujing Lin, Dawei Wang, Xiangqian Zhao, Zexin Feng, Yangkun Shen, Qi Chen · 2025 · International Journal of Molecular Sciences
STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity
Nicole A. Wilski, Colby Stotesbury, Christina Del Casale, Brian Montoya, Eric B. Wong, Luis J. Sigal, Christopher M. Snyder · 2020 · The Journal of Immunology
Tumour-specific STING agonist synthesis via a two-component prodrug system
Nai‐Shu Hsu, Cong Tang, Raquel Valente Mendes, Carlos Labão‐Almeida, C.V. dos Reis, Ana Raquel Coelho, Marta C. Marques, Mar Cabeza-Cabrerizo, Roman Misteli, Timothy P. C. Rooney et al. · 2025 · Nature Chemistry
Overcoming Immune Therapy Resistance in Cancer Through Innate Immune Reprogramming
Giada Mandracci, Nardine Soliman, Nadia El Khawanky · 2025 · International Journal of Molecular Sciences
MTAP deficiency confers resistance to cytosolic nucleic acid sensing and STING agonists
Jung-Mao Hsu, Chunxiao Liu, Weiya Xia, Chung‐Yu Chen, Wei‐Chung Cheng, Junwei Hou, Mien‐Chie Hung · 2025 · Science
Targeting DNA Damage Response and Immune Crosstalk in Cancer: Mechanistic Insights and Therapeutic Opportunities
Lavinia Florica Mărcuț, Roxana Daniela Brata, Alina Cristina Barb, Alexia Manole, Dan Gabriel Stef, Cristina Ștefania Dumitru, Flavia Zara, Raul Pătrașcu · 2025 · International Journal of Molecular Sciences
Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists
Jessica N. Filderman, Jennifer L. Taylor, Jianmin Wang, Yali Zhang, Prashant Kumar Singh, Mark A. Ross, Simon C. Watkins, Ayah Nedal Al-Bzour, Lilit Karapetyan, Paweł Kaliński et al. · 2024 · Frontiers in Immunology
Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity
Yifang Dang, Mingtong Ma, Yan Wang, Mengmeng Zhao, Yajuan Cao, Hang Su, Tianhao Liu, Mengge Zheng, Jiani Gao, Xiangyang Wu et al. · 2025 · Cell Reports
Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies
Khiyam Hussain, Mark Steven Cragg, Stephen A. Beers · 2021 · Cancers
Development of Small-Molecule STING Activators for Cancer Immunotherapy
Hee Ra Jung, Seongman Jo, Min Jae Jeon, Hyelim Lee, Yeonjeong Chu, Jeehee Lee, Eunha Kim, Gyu‐Yong Song, Cheulhee Jung, Hyejin Kim et al. · 2021 · Biomedicines
AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production
Estefanía Rodríguez‐García, Nerea Zabaleta, Irene Gil-Fariña, Manuela González-Aparicio, Maite Echeverz, Heike Bähre, Cristina Solano, Íñigo Lasa, Gloria González‐Aseguinolaza, Mirja Hommel · 2020 · The Journal of Immunology
Emerging immunological strategies: recent advances and future directions
Hongyun Zhao, Fan Luo, Jinhui Xue, Su Li, Rui‐Hua Xu · 2021 · Frontiers of Medicine
Research progress on mitochondria regulating tumor immunity
Jing Li, Pinglong Xu, Shasha Chen · 2024 · Journal of Zhejiang University (Medical Sciences)
Discovery of a non‐nucleotide stimulator of interferon genes (STING) agonist with systemic antitumor effect
Xiyuan Wang, Zhengsheng Zhan, Zhen Wang, Yan Zhang, Kaiyan Zhao, Li Han, Xiaoqian Zhou, Yuting Guo, Fengying Fan, Jian Ding et al. · 2024 · MedComm
Reciprocal regulation between ferroptosis and STING-type I interferon pathway suppresses head and neck squamous cell carcinoma growth through dendritic cell maturation
Mingyu Li, Shufang Jin, Hailong Ma, Xi Yang, Zhiyuan Zhang · 2025 · Oncogene
A cGAS-STING pathway activating cobalt(III) cyclam prodrug for combined chemotherapy and immunotherapy of breast cancer
Haiqin Song, Nicolás Montesdeoca, Elizaveta Efanova, Xuan Li, Johannes Karges, Haihua Xiao, Kun Shang, Hanchen Zhang · 2025 · Journal of Controlled Release
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses
Amanda J. Oliver, Simon P. Keam, Bianca von Scheidt, Damien J. Zanker, Aaron J Harrison, Daniela G.M. Tantalo, Phillip Kevin Darcy, Michael H. Kershaw, Clare Y. Slaney · 2020 · OncoImmunology
18F-FDG PET Visualizes Systemic STING Agonist-Induced Lymphocyte Activation in Preclinical Models
Thuc M. Le, Hailey R. Lee, Evan R. Abt, Khalid Rashid, Amanda L. Creech, Keke Liang, Jing Cui, Arthur Eung-Hyuck Cho, Wei Liu, Amanda N. Labora et al. · 2022 · Journal of Nuclear Medicine
Manganese facilitated cGAS-STING-IFNI pathway activation induced by ionizing radiation in glioma cells
Yu‐Ping He, Ying Yang, Wenpeng Huang, Shuangyu Yang, Xuefei Xue, Kun Zhu, Huiling Tan, Ting Sun, Wei Yang · 2023 · International Journal of Radiation Biology
Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
Jenny Schunke, Volker Mailänder, Katharina Landfester, Michael Fichter · 2023 · International Journal of Molecular Sciences
Exosome co-delivery of a STING agonist augments immunogenicity elicited by CVB3 VP1 vaccine via promoting antigen cross-presentation of CD8 + DCs
Changwei Zhang, Qinghui Cao, Yuanyu Li, Juan Lu, Sidong Xiong, Yan Yue · 2024 · International Journal of Biological Macromolecules
Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses
Rita Turpin, Karita Peltonen, Jenna H. Rannikko, Ruixian Liu, Anita N. Kumari, Daniel Nicorici, Moon Hee Lee, Minna Mutka, Panu E. Kovanen, Laura Niinikoski et al. · 2025 · OncoImmunology
Interaction of intratumoral microbiota with the tumor immune microenvironment and its impact on cancer progression
Yan Tingting, Zhu Xiaoling, Yu Zhang, Yan Luo, Yang Luo, Shang Xueqin, Tang Shikai · 2025 · Frontiers in Oncology
Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy
Jordan D. Lewicky, Alexandrine L. Martel, Nya L. Fraleigh, Emilie Picard, Leila Mousavifar, Arnaldo Nakamura, Francisco Díaz‐Mitoma, René Roy, Hoang‐Thanh Le · 2022 · Pharmaceutics
Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer
Naomi Sugimura, Eiji Kubota, Yoshinori Mori, Mineyoshi Aoyama, Mamoru Tanaka, Takaya Shimura, Satoshi Tanida, Randal N. Johnston, Hiromi Kataoka · 2023 · Cancer Immunology Immunotherapy
m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma
Zhen-Dong Huang, Lulu Lin, Zizhen Liu, Chao Hu, Hui-Yun Gu, Renxiong Wei · 2021 · Frontiers in Immunology
The LRRC8A:C Heteromeric Channel Is a cGAMP Transporter and the Dominant cGAMP Importer in Human Vasculature Cells
Lauren J. Lahey, Xianlan Wen, Rachel E. Mardjuki, Volker Böhnert, Gaelen T. Hess, Christopher Ritchie, Jacqueline A. Carozza, Merritt C. Maduke, Michael Cory Bassik, Lingyin Li · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Intratumoral STING activation causes durable immunogenic tumor eradication in the KP soft tissue sarcoma model
Kayla Marritt, Karys M. Hildebrand, Kurt Hildebrand, Arvind K. Singla, Franz J. Zemp, Douglas J. Mahoney, Frank Robert Jirik, Michael J. Monument · 2023 · Frontiers in Immunology
Advances in nanoplatform-based multimodal combination therapy activating STING pathway for enhanced anti-tumor immunotherapy
Huizhong Zhang, Xiaohan Xu, Shiman Li, Huating Huang, Ke Zhang, Wenjing Li, Xinzhu Wang, Jingwen Yang, Xingbin Yin, Changhai Qu et al. · 2025 · Colloids and Surfaces B Biointerfaces
STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity
Mélanie Girard, Tianning Yu, Nathália Vieira Batista, Karen K M Yeung, Sara Lamorte, Wenting Gao, Miaoxi Liu, Tracy L. McGaha, Tania H. Watts · 2025 · The Journal of Immunology
ENPP1 inhibitor with ultralong drug-target residence time as an innate immune checkpoint blockade cancer therapy
Songnan Wang, Randolph M. Johnson, Jacqueline A. Carozza, Daniel Fernández, Jan J. Scicinski, Neil A. Verity, Rachel E. Mardjuki, Xujun Cao, Yingjie Guo, Jacqueline S. Papkoff et al. · 2025 · Cell Reports Medicine
Systemic administration of STING agonist promotes myeloid cells maturation and antitumor immunity through regulating hematopoietic stem and progenitor cell fate
Tianxiao Xu, Jie Dai, Lirui Tang, Linzi Sun, Lu Si, Jun Guo · 2023 · Cancer Immunology Immunotherapy
Engaging Pattern Recognition Receptors in Solid Tumors to Generate Systemic Antitumor Immunity
Michael C. Brown · 2022 · Cancer treatment and research
Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists
Xue Liu, Mingjin Wang, Minjian Yang, Hanyu Sun, Baolian Wang, Xiandao Pan, Xiaoguang Chen, Jing Jin, Xiaojian Wang · 2022 · European Journal of Medicinal Chemistry
Lipid nanoparticles delivering constitutively active STING mRNA as a novel anti-cancer therapeutic approach
Wei Liu, Mohamad‐Gabriel Alameh, June F. Yang, Jonathan R. Xu, Paulo J.C. Lin, Ying K. Tam, Drew Weissman, Jianxin You · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells
Michael Herbst, Hakan Köksal, Silvan Brunn, Dominik Zanetti, Ioana Domocos, Viola De Stefani, Marco Gatti, Francesca Vivalda, Paulo Pereira, Marc Nater et al. · 2025 · Cell Reports
Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor Activity
Hui Hou, Jingyi Zhou, Qibang Sui, Changfa Zhang, Zhaoming Su, Rongrong Cui, Bin Shan, Peijia Xu, Zhengyang Chen, Bing Jiang et al. · 2025 · Journal of Medicinal Chemistry
Role of PLK4 inhibition in cancer therapy
Kishore Banik, Thomas J. Hayman · 2025 · Cancer and Metastasis Reviews
Immunometabolic Rewiring of Dendritic Cells to Overcome Glutamine‐Driven Immune Suppression in Colorectal Cancer
Bingjie Zhang, Renming Fan, Yongrui Hai, Ye Chen, Xintong Lu, Wenhui Wang, Jiarui Dou, Jiaxin Yan, Chang Su, Yue Chen et al. · 2025 · Advanced Science
Self-Carrier Nanoagonist Enabling Positive Feedback Regulation of Cuproptosis-Immunity for Potent Antitumor Therapy
Minhao Jiang, Penghui Li, Yinuo Shu, Guoshi Xu, Yinghua Peng, Fang Pu, Anjun Song, Jinsong Ren, Xiaogang Qu · 2026 · ACS Nano